These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2207304)

  • 21. Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.
    Nakashima M; Uematsu T; Kosuge K; Okuyama Y; Morino A; Ozaki M; Takebe Y
    J Clin Pharmacol; 1994 Sep; 34(9):930-7. PubMed ID: 7983237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lomefloxacin on theophylline pharmacokinetics.
    Nix DE; Norman A; Schentag JJ
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1006-8. PubMed ID: 2675751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ranitidine on renal clearance of lomefloxacin.
    Sudoh T; Fujimura A; Harada K; Sunaga K; Ohmori M; Sakamoto K
    Eur J Clin Pharmacol; 1996; 51(1):95-8. PubMed ID: 8880059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose].
    Guibert J; Kitzis MD; Acar JF; Masquelier AM; Bellanger B
    Pathol Biol (Paris); 1989 May; 37(5):411-4. PubMed ID: 2506515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of experimental Salmonella typhimurium infection in mice with lomefloxacin.
    Butler T; Cartagenova M; Dunn D
    J Antimicrob Chemother; 1990 Apr; 25(4):629-34. PubMed ID: 2190972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG; Saltvedt E; Walstad RA; Marstein S
    Am J Med; 1992 Apr; 92(4A):38S-40S. PubMed ID: 1316068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
    Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
    J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
    Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
    Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg.
    Montay G; Bruno R; Vergniol JC; Ebmeier M; Le Roux Y; Guimart C; Frydman A; Chassard D; Thebault JJ
    J Clin Pharmacol; 1994 Nov; 34(11):1071-6. PubMed ID: 7876398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
    Leigh DA; Harris C; Tait S; Walsh B; Hancock P
    J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects.
    Stass H; Dalhoff A; Kubitza D; Schühly U
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2060-5. PubMed ID: 9687407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of temafloxacin in humans after single oral doses.
    Granneman GR; Carpentier P; Morrison PJ; Pernet AG
    Antimicrob Agents Chemother; 1991 Mar; 35(3):436-41. PubMed ID: 2039194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
    Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
    J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
    Kisicki JC; Griess RS; Ott CL; Cohen GM; McCormack RJ; Troetel WM; Imbimbo BP
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1296-301. PubMed ID: 1329618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.
    Picollo R; Brion N; Gualano V; Millérioux L; Marchetti M; Rosignoli MT; Dionisio P
    Arzneimittelforschung; 2003; 53(3):201-5. PubMed ID: 12705176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentrations of oral lomefloxacin in serum and bronchial mucosa.
    Baldwin DR; Honeybourne D; Andrews JM; Ashby JP; Wise R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1017-9. PubMed ID: 2393260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.